Publication:

Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen

Thumbnail Image

Open/View Files

5291715.pdf (213.17 KB)

Date

2017

Authors

Published Version

10.14309/crj.2017.16

Journal Title

Journal ISSN

Volume Title

Publisher

American College of Gastroenterology
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Ahmed Sakr, Ayman, Jasmine M. Hanifi, and Ming Valerie Lin. 2017. “Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen.” ACG Case Reports Journal 4 (1): e16. doi:10.14309/crj.2017.16. http://dx.doi.org/10.14309/crj.2017.16.

Abstract

Mixed hepatitis C virus (HCV) genotype infection is emerging with improved methods of detection. It is commonly seen in hemodialysis patients and intravenous drug users due to repeated HCV exposure and absence of protective immunity, and can contribute to treatment failure. Direct-acting antiviral regimens have been extensively studied in patients with different individual HCV genotypes; however, there are no reported data on their use in patients with mixed HCV genotype. We present a case of mixed HCV genotype 1a and 2 infection in a decompensated cirrhotic patient treated successfully with sofosbuvir, ledipasvir, and ribavirin.

Description

Other Available Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291715/pdf/

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731699

Collections

HMS Scholarly Articles

Endorsement

Review

Supplemented By

Related Stories